Media headlines about NanoString Technologies (NASDAQ:NSTG) have trended somewhat positive recently, Accern Sentiment reports. Accern identifies negative and positive news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. NanoString Technologies earned a media sentiment score of 0.12 on Accern’s scale. Accern also assigned media stories about the biotechnology company an impact score of 47.059776492622 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
Several equities analysts recently issued reports on NSTG shares. Zacks Investment Research upgraded NanoString Technologies from a “sell” rating to a “hold” rating in a research note on Tuesday, July 25th. BidaskClub lowered NanoString Technologies from a “sell” rating to a “strong sell” rating in a research note on Friday, July 28th. Cowen and Company reiterated a “buy” rating and issued a $20.00 price objective on shares of NanoString Technologies in a research note on Thursday, September 28th. Janney Montgomery Scott lowered NanoString Technologies from a “buy” rating to a “neutral” rating in a research note on Thursday, October 12th. Finally, Robert W. Baird lowered their price objective on NanoString Technologies from $23.00 to $19.00 and set an “outperform” rating on the stock in a research note on Thursday, October 12th. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $17.25.
Shares of NanoString Technologies (NASDAQ NSTG) opened at $8.24 on Wednesday. NanoString Technologies has a 12-month low of $7.32 and a 12-month high of $23.41. The company has a quick ratio of 2.89, a current ratio of 3.35 and a debt-to-equity ratio of 1.08.
NanoString Technologies (NASDAQ:NSTG) last posted its quarterly earnings data on Thursday, November 2nd. The biotechnology company reported ($0.45) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.56) by $0.11. The firm had revenue of $27.02 million for the quarter, compared to the consensus estimate of $26.27 million. NanoString Technologies had a negative return on equity of 174.55% and a negative net margin of 44.24%. The business’s revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.51) EPS. sell-side analysts predict that NanoString Technologies will post -1.77 earnings per share for the current year.
TRADEMARK VIOLATION NOTICE: “Somewhat Favorable News Coverage Somewhat Unlikely to Affect NanoString Technologies (NSTG) Share Price” was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another domain, it was copied illegally and reposted in violation of U.S. and international trademark & copyright law. The original version of this piece can be read at https://www.dispatchtribunal.com/2017/11/22/somewhat-positive-press-coverage-somewhat-unlikely-to-affect-nanostring-technologies-nstg-share-price.html.
About NanoString Technologies
NanoString Technologies, Inc develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample.
Receive News & Ratings for NanoString Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.